298 related articles for article (PubMed ID: 17125710)
1. [Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy].
Laredo R; Monserrat L; Hermida-Prieto M; Fernández X; Rodríguez I; Cazón L; Alvariño I; Dumont C; Piñón P; Peteiro J; Bouzas B; Castro-Beiras A
Rev Esp Cardiol; 2006 Oct; 59(10):1008-18. PubMed ID: 17125710
[TBL] [Abstract][Full Text] [Related]
2. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
[TBL] [Abstract][Full Text] [Related]
3. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.
Perrot A; Schmidt-Traub H; Hoffmann B; Prager M; Bit-Avragim N; Rudenko RI; Usupbaeva DA; Kabaeva Z; Imanov B; Mirrakhimov MM; Dietz R; Wycisk A; Tendera M; Gessner R; Osterziel KJ
J Mol Med (Berl); 2005 Jun; 83(6):468-77. PubMed ID: 15856146
[TBL] [Abstract][Full Text] [Related]
5. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
[TBL] [Abstract][Full Text] [Related]
6. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
Chiou KR; Chu CT; Charng MJ
J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.
Posen BM; Moolman JC; Corfield VA; Brink PA
Br Heart J; 1995 Jul; 74(1):40-6. PubMed ID: 7662452
[TBL] [Abstract][Full Text] [Related]
8. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.
Revera M; van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
Cardiovasc Res; 2008 Mar; 77(4):687-94. PubMed ID: 18029407
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
11. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
[TBL] [Abstract][Full Text] [Related]
12. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M
Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression.
Revera M; Van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
Cardiovasc J Afr; 2007; 18(3):146-53. PubMed ID: 17612745
[TBL] [Abstract][Full Text] [Related]
14. [Screening and analysis of the mutations on beta-myosin heavy chain gene in 3 Chinese families with hypertrophic cardiomyopathy].
Feng XL; Fan XP; Yang ZW; Yang FH
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):110-3. PubMed ID: 21426742
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
[TBL] [Abstract][Full Text] [Related]
16. [The genotype-phenotype correlation of MYH7 gene G15391A mutation and MYBPC3 gene G12101A mutation in familial hypertrophic cardiomyopathy].
WANG H; ZOU YB; WANG JZ; SONG L; SUN K; SONG XD; WANG XJ; ZHANG CN; HUI RT
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1059-62. PubMed ID: 19134269
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of MYH7, MYBPC3 and TNNT2 gene mutations in 10 Chinese pedigrees with familial hypertrophic cardiomyopathy and the correlation between genotype and phenotype].
Liu WL; Xie WL; Hu DY; Zhu TG; Li YT; Sun YH; Li CL; Li L; Li TC; Bian H; Tong QG; Yang SN; Fan RY; Cui W
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):202-7. PubMed ID: 16630449
[TBL] [Abstract][Full Text] [Related]
18. A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family.
Huang X; Song L; Ma AQ; Gao J; Zheng W; Zhou X; Zhang Q; Lu H; Li Y; Liu Y; Hui R
Clin Chim Acta; 2001 Aug; 310(2):131-9. PubMed ID: 11498078
[TBL] [Abstract][Full Text] [Related]
19. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
[TBL] [Abstract][Full Text] [Related]
20. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
